Juárez BI, Herrera VJE

Language: Spanish
References: 15
Page: 10-14
PDF size: 578.26 Kb.

ABSTRACT

Introduction: primary postpartum hemorrhage (PPH) is a leading cause of maternal mortality worldwide. Vaginal clamping of uterine arteries is an effective alternative for PPH control in resource-limited settings. Objective: to describe the experience with vaginal clamping in PPH at a hospital without an on-site blood bank. Material and methods: an observational, descriptive, and retrospective study. Twenty-two cases involving vaginal clamping of uterine arteries were analyzed out of 53 PPH records at Valle de Bravo General Hospital (January-December 2023). Results: the mean age was 22.2 years (68.1% under age 25), with 88% being full-term pregnancies. Predominant risk factors included preeclampsia, gestational diabetes, and anemia. Uterine atony was the main cause of PPH and the primary indication for clamping. The mean clamping time was 6 hours. Hypovolemic shock grade II-III was present in 36.3% of patients, with an average blood volume loss of 33.5%. Conclusions: the incidence of PPH was 0.6%, lower than reported in the literature. Vaginal clamping of uterine arteries is an effective and reproducible option to decrease bleeding volume and reduce maternal morbidity in hospitals lacking a blood bank.

REFERENCES

1. World Health Organization. Maternal mortality: Evidence brief. Geneva: WHO; 2023.

2. Secretaría de Salud (MX). Informe Semanal de Vigilancia Epidemiológica: Mortalidad Materna, Semana Epidemiológica 52. Ciudad de México: Dirección General de Epidemiología; 2023.

3. Escobar MF, Nassar AH, Theron G, Barnea ER, Nicholson S, Ramasauskaite D et al. Postpartum hemorrhage: New insights for definition and management. Rev Bras Ginecol Obstet. 2022; 44 (11): 1012-1017.

4. Sentilhes L, Weiniger CF, Deneux-Tharaux C, Javier H, Al-Khatari S, Al-Widian R et al. Postpartum hemorrhage: FIGO/ICM guidelines. Int J Gynaecol Obstet. 2021; 154 (S1): 4-11.

5. Wormer KC, Jamil RT, Bryant SB. Postpartum hemorrhage. Treasure Island (FL): StatPearls Publishing; 2023.

6. Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2019; 4 (4): CD011689.

7. Widmer M, Piaggio G, Nguyen TMH, Osoti A, Owa OO, Misra S et al. Heat-stable carbetocin versus oxytocin for postpartum hemorrhage prevention. N Engl J Med. 2018; 378 (26): 2482-2491.

8. Parry S, Meyer CA, Kumar S. Management of postpartum hemorrhage: a review of strategy and drugs. J Clin Med. 2022; 11 (16): 4723.

9. Suarez S, Conde-Agudelo A, Portela-House A, Mella MT, Wright D, Espitia-De La Hoz FJ et al. Uterine balloon tamponade for postpartum hemorrhage: a systematic review. Am J Obstet Gynecol. 2020; 222 (4): 293.e1-293.e52.

10. Abalos E, Giugliani C, García-Elorrio E, Vais A, Lede R, Anyagaligbo O et al. FIGO recommendations on management of postpartum hemorrhage. Int J Gynaecol Obstet. 2021; 152 (3): 312-317.

11. García-Pineda A, Pérez-Mendoza J, Morales-Ríos O. Técnica de Zea: una alternativa vigente en la hemorragia obstétrica. Rev Mex Obstet Ginecol. 2021; 89 (5): 342-348.

12. Bautista-Gómez E, Martínez-López L, Reyes-Cruz G. Pinzamiento vaginal de arterias uterinas en hemorragia postparto. J Health Med Sci. 2020; 6 (3): 145-151.

13. Mendoza-Calderón S, Valerio-Castro E, Luna-Magaña M. Efectividad del pinzamiento de arterias uterinas (Técnica de Zea). Ginecol Obstet Mex. 2022; 90 (4): 315-322.

14. World Health Organization. WHO recommendations on non-drug interventions for postpartum hemorrhage. Geneva: WHO; 2020.

15. López-Morales SM, Martínez-Ramírez R, Sánchez-López G. Manejo de hemorragia obstétrica en hospitales de segundo nivel sin banco de sangre. Rev Sanid Milit. 2023; 77 (1): 12-19.